Overview / Abstract: |
This live symposium coverage at the CRT Conference 2017 in Washington D.C. features expert faculty who discuss current changes and challenges in LDL management in an evolving therapeutic environment. New therapeutic agents, including PCSK9 inhibitors and their role in the existing statin-based drug armamentarium, are evaluated from a risk-benefit profile as an option for treating populations who may not be good candidates for statin therapy. Newly issued cholesterol guidelines for managing both LDL and HDL levels are also evaluated, along with a comprehensive discussion of current ASCVD diagnostic criteria for various populations and risk stratifications. |
Expiration |
Mar 31, 2018 |
Discipline(s) |
Informatics / Coding / Billing CE, Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME, Radiology / RAD Tech CE |
Format |
Webinar / Webcast / Video |
Credits / Hours |
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
Accreditation |
ACCME |
Is This Activity Certified for "Live" Credit? |
YES |
Presenters / Authors / Faculty |
Michael Davidson, MD Dinesh Kalra, MD, FACC Peter Libby, MD |
Activity Specialities / Related Topics |
Cardiology / Cardiovascular, Diabetes, Dyslipidemia / Cholesterol, Family Medicine, Geriatrics / LTC, Hypertension / Blood Pressure, Obesity / Weight Management, Podiatry, Preventive Care, Primary Care |
Sponsors / Supporters / Grant Providers |
This activity is supported by educational funding provided by Amgen. |
Keywords / Search Terms |
ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Webcasts, Live Meetings, Cardiologist, Guidelines, Cholesterol, Injection, Binding, Blood plasma, Removal of particles , Blood stream, Heart/blood, Liver, Lipids, Hypercholesterolemia , LDLs, LDL Management, PCSK9, PCSK9 Inhibitors, Statins, Statin intolerance, Muscle pain, Muscle weakness, Coronary plaque, High-risk patients, Familial hypercholesterolemia Free CE CME Live CE CME |